Anti-B7-H3 Antibody, Rabbit Polyclonal sinobiological 11188-T24

$143.00
In stock
SKU
11188-T24
Catalog No.SizePrice (USD)
11188-T24-5050 µL$147.96
11188-T24-100100 µL$251.64
11188-T24-200200 µL$355.32

General Information

Product nameAnti-B7-H3 Antibody, Rabbit Polyclonal
Validated applicationsELISA (FAQ Protocol), IHC-P (FAQ Protocol)
Species reactivityReacts with: Human
SpecificityHuman B7-H3
ImmunogenRecombinant Human B7-H3/CD276 Protein (Catalog#11188-H08H)
PreparationProduced in rabbits immunized with purified, recombinant Human B7-H3/CD276 (rh B7-H3/CD276; Catalog#11188-H08H; Q5ZPR3-1; Met1-Thr461). B7-H3/CD276 specific IgG was purified by Human B7-H3/CD276 affinity chromatography.
SourcePolyclonal Rabbit IgG
PurificationProtein A & Antigen Affinity
Formulation0.2 μm filtered solution in PBS
ConjugateUnconjugated
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Synonyms: Anti-B7-H3 Antibody; Anti-B7H3 Antibody; Anti-B7RP-2 Antibody; Anti-PSEC0249 Antibody; Anti-UNQ309/PRO352 Antibody

Image / Experimental Information

Image 1 DescriptionImmunochemical staining of human B7H3 in human ovarian cancer with rabbit polyclonal antibody at 1:5000 dilution, formalin-fixed paraffin embedded sections.
Image 1 Alt TextHuman B7-H3/CD276 Immunohistochemistry(IHC) 18037
Image 1 URLSource image
Image 2 DescriptionImmunochemical staining of human B7H3 in human ovarian cancer with rabbit polyclonal antibody at 1:5000 dilution, formalin-fixed paraffin embedded sections.
Image 2 Alt TextHuman B7-H3/CD276 Immunohistochemistry(IHC) 18038
Image 2 URLSource image

Background Information

Full NameCD276 molecule
DescriptionB7-H3 is a member of the B7 family of immune regulatory ligands that is thought to attenuate peripheral immune responses through co-inhibition. It plays an important role in adaptive immune responses, and was shown to either promote or inhibit T-cell responses in various experimental systems. B7-H3 may play an important role in muscle-immune interactions, providing further evidence of the active role of muscle cells in local immunoregulatory processes. B7-H3 is a novel protein structurally related to the B7 family of ligands by the presence of a single set of immunoglobulin-V-like and immunoglobulin-C-like (VC) domains. Previous studies have correlated its overexpression with poor prognosis and decreased tumor-infiltrating lymphocytes in various carcinomas including uterine endometrioid carcinomas, and mounting evidence supports an immuno-inhibitory role in ovarian cancer prognosis. Recently, B7-H3 expression has been reported in several human cancers indicating an additional function of B7-H3 as a regulator of antitumor immunity.
Research Areas
  • Cancer Drug Targets
Tags
  • Cancer Immunotherapy
  • Co-inhibitory Immune Checkpoint Targets
  • Immune Checkpoint
  • Immune Checkpoint Detection: Antibodies
  • Immune Checkpoint Detection: ELISA Antibodies
  • Immune Checkpoint Detection: FCM Antibodies
  • Immune Checkpoint Detection: ICC Antibodies
  • Immune Checkpoint Detection: IP Antibodies
  • Immune Checkpoint Detection: WB Antibodies
  • Immune Checkpoint Targets
  • Immunotherapy
  • Targeted Therapy
References
  1. Suh WK, et al. (2004) The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc Natl Acad Sci U S A. 101(35): 12969-73.
  2. Waschbisch A, et al. (2008) Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions. Arthritis Rheum. 58(11): 3600-8.
  3. Loos M, et al. (2010) B7-h3 and its role in antitumor immunity. Clin Dev Immunol. 2010: 683875.
  4. Zang X, et al. (2010) Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod Pathol. 23(8): 1104-12.
  5. Sun J, et al. (2010) Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother. 59(8): 1163-71.

title: Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma.
authors: Shiyuan Liu; Tian Guan; ...; Xianjun Zhang
journal: BMC Cancer
date: 2025-04-02
pmid: 40169956
cited_by_count: 2
techniques: CCK-8 Assay; Comparison; Control; Expressing; Flow Cytometry; Fluorescence; Immunohistochemistry; Incubation; Lysis; Membrane; Negative Control
bioz_score: 93

title: Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
authors: Jenny Mattsson; Ludvig Ekdahl; ...; Björn Nilsson
journal: Nature Communications
date: 2021-02-24
pmid: 33627649
doi: 10.1038/s41467-021-21518-4
pmcid: 7904777
cited_by_count: 3
techniques: Produced; Recombinant
bioz_score: 93

Reviews

Write Your Own Review
You're reviewing:Anti-B7-H3 Antibody, Rabbit Polyclonal sinobiological 11188-T24
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.